TY - JOUR
T1 - A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
AU - Ashar, Foram N.
AU - Mitchell, Rebecca N.
AU - Albert, Christine M.
AU - Newton-Cheh, Christopher
AU - Brody, Jennifer A.
AU - Müller-Nurasyid, Martina
AU - Moes, Anna
AU - Meitinger, Thomas
AU - Mak, Angel
AU - Huikuri, Heikki
AU - Junttila, M. Juhani
AU - Goyette, Philippe
AU - Pulit, Sara L.
AU - Pazoki, Raha
AU - Tanck, Michael W.
AU - Blom, Marieke T.
AU - Zhao, Xiaoqing
AU - Havulinna, Aki S.
AU - Jabbari, Reza
AU - Glinge, Charlotte
AU - Tragante, Vinicius
AU - Escher, Stefan A.
AU - Chakravarti, Aravinda
AU - Ehret, Georg
AU - Coresh, Josef
AU - Li, Man
AU - Prineas, Ronald J.
AU - Franco, Oscar H.
AU - Kwok, Pui Yan
AU - Lumley, Thomas
AU - Dumas, Florence
AU - McKnight, Barbara
AU - Rotter, Jerome I.
AU - Lemaitre, Rozenn N.
AU - Heckbert, Susan R.
AU - O'Donnell, Christopher J.
AU - Hwang, Shih Jen
AU - Tardif, Jean Claude
AU - VanDenburgh, Martin
AU - Uitterlinden, André G.
AU - Hofman, Albert
AU - Stricker, Bruno H.C.
AU - De Bakker, Paul I.W.
AU - Franks, Paul W.
AU - Jansson, Jan Hakan
AU - Asselbergs, Folkert W.
AU - Halushka, Marc K.
AU - Maleszewski, Joseph J.
AU - Tfelt-Hansen, Jacob
AU - Engstrøm, Thomas
AU - Salomaa, Veikko
AU - Virmani, Renu
AU - Kolodgie, Frank
AU - Wilde, Arthur A.M.
AU - Tan, Hanno L.
AU - Bezzina, Connie R.
AU - Eijgelsheim, Mark
AU - Rioux, John D.
AU - Jouven, Xavier
AU - Kääb, Stefan
AU - Psaty, Bruce M.
AU - Siscovick, David S.
AU - Arking, Dan E.
AU - Sotoodehnia, Nona
N1 - Funding Information:
AGNES: Netherlands Heart Foundation (Grant Numbers 2001D019, 2003T302, and 2007B202; grant 2005T024 to C.R.B.; CVON project PREDICT); the Leducq Foundation (Grant 05-CVD); the Center for Translational Molecular Medicine (CTMM COHFAR); and the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici Project number: 016.150.610 to C.R.B.]. ARREST: Netherlands Heart Foundation, CVON project 2017-15 RESCUED; the European Union’s Horizon 2020 research and innovation programme under acronym ESCAPE-NET (Grant Number 733381); the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616 to H.L.T.);
Funding Information:
and the Medicines Evaluation Board Netherlands (CBG/MEB to H.L.T.). ARIC: National Heart, Lung, and Blood Institute (Contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C Grant Numbers R01HL087641, R01HL59367, and R01HL086694); National Human Genome Research Institute (Contract U01HG004402); National Institutes of Health (Contract HHSN268200625226C); the National Institutes of Health and NIH Roadmap for Medical Research (Grant Number UL1RR025005); and the National Institutes of Health (Grant Numbers R01HL11267 and R01HL116747 to F.NA., R.N.M, A.M., and D.E.A.). CABS: National Heart, Lung, and Blood Institute (Grant Numbers HL111089, HL088456, HL088576, HL091244, HL116747, and HL092111); the Laughlin Family; and the John Locke and Medic One Foundations. CARTAGENE: French National Institute of Medical and Scientific Research (INSERM); Direction Générale de la Santé (French ministry of Health); and a French German grant BMBF-ANR for the genetic analyses. CHS: National Heart, Lung, and Blood Institute (Contract Numbers HHSN268201200036C, HHSN268200800007C, HHSN26820 1800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and Grant Numbers U01HL080295, R01HL085251, R01HL087652, R01HL105756, R01HL103612, R01HL120393, and U01HL130114); the National Institute of Neurological Disorders and Stroke; National Institute on Aging (Grant Number AG023629); National Center for Advancing Translational Sciences (Grant Number UL1TR001881); the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (Grant Number DK063491); the National Institutes of Health (Grant Numbers HL111089 and HL116747 to N.S.), and the Laughlin Family Endowment (to N.S.). A full list of CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. FHS: National Heart, Lung, and Blood Institute (Grant Numbers HL-54776 and HL-54776); and the United States Department of Agriculture Research Service (Contracts 53-K06-5-10 and 58-1950-9-001); the National Heart, Lung, and Blood Institute Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc. (Contract No. N02-HL-6-4278); and the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. FINGESTURE: Sigrid Juselius Foundation (Helsinki, Finland); the Council of Health of the Academy of Finland (Helsinki, Finland); and the Montreal Heart Institute Foundation. FINRISK: V.S. was supported by the Finnish Foundation for Cardiovascular Research. GEVAMI: University of Copenhagen (Copenhagen, Denmark); The Danish National Research Foundation (Copenhagen, Denmark); The John and Birthe Meyer Foundation (Copenhagen, Denmark); The Research Foundation of the Heart Center Rigshospitalet (Copenhagen, Denmark); and The Bikuben Scholar-Danmark-Amerika Fonden & Fulbright Commission (Copenhagen, Denmark). The KORA study was initiated and financed by the Helmholtz Zentrum München - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universität, as part of LMUinnovativ. HARVARD: National Heart, Lung, and Blood Institute (Grant Numbers HL-092111, HL-068070, HL-26490, HL-34595, HL-34594, HL-35464, HL-46959, and HL-080467) and the National Cancer Institute (Grant Numbers CA-34944, CA-40360, CA-55075, CA-87969, and CA-97193). ROTTERDAM: Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII); the Municipality of Rotterdam; the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012); the Research Institute for Diseases in the Elderly (014-93-015; RIDE2); and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) (project nr. 050-060-810).
Publisher Copyright:
© 2018 Oxford University Press.
PY - 2018/11/21
Y1 - 2018/11/21
N2 - Aims Sudden cardiac arrest (SCA) accounts for 10% of adult mortality in Western populations. We aim to identify potential loci associated with SCA and to identify risk factors causally associated with SCA. Methods and results We carried out a large genome-wide association study (GWAS) for SCA (n = 3939 cases, 25 989 non-cases) to examine common variation genome-wide and in candidate arrhythmia genes. We also exploited Mendelian randomization (MR) methods using cross-trait multi-variant genetic risk score associations (GRSA) to assess causal relationships of 18 risk factors with SCA. No variants were associated with SCA at genome-wide significance, nor were common variants in candidate arrhythmia genes associated with SCA at nominal significance. Using cross-trait GRSA, we established genetic correlation between SCA and (i) coronary artery disease (CAD) and traditional CAD risk factors (blood pressure, lipids, and diabetes), (ii) height and BMI, and (iii) electrical instability traits (QT and atrial fibrillation), suggesting aetiologic roles for these traits in SCA risk. Conclusions Our findings show that a comprehensive approach to the genetic architecture of SCA can shed light on the determinants of a complex life-threatening condition with multiple influencing factors in the general population. The results of this genetic analysis, both positive and negative findings, have implications for evaluating the genetic architecture of patients with a family history of SCA, and for efforts to prevent SCA in high-risk populations and the general community.
AB - Aims Sudden cardiac arrest (SCA) accounts for 10% of adult mortality in Western populations. We aim to identify potential loci associated with SCA and to identify risk factors causally associated with SCA. Methods and results We carried out a large genome-wide association study (GWAS) for SCA (n = 3939 cases, 25 989 non-cases) to examine common variation genome-wide and in candidate arrhythmia genes. We also exploited Mendelian randomization (MR) methods using cross-trait multi-variant genetic risk score associations (GRSA) to assess causal relationships of 18 risk factors with SCA. No variants were associated with SCA at genome-wide significance, nor were common variants in candidate arrhythmia genes associated with SCA at nominal significance. Using cross-trait GRSA, we established genetic correlation between SCA and (i) coronary artery disease (CAD) and traditional CAD risk factors (blood pressure, lipids, and diabetes), (ii) height and BMI, and (iii) electrical instability traits (QT and atrial fibrillation), suggesting aetiologic roles for these traits in SCA risk. Conclusions Our findings show that a comprehensive approach to the genetic architecture of SCA can shed light on the determinants of a complex life-threatening condition with multiple influencing factors in the general population. The results of this genetic analysis, both positive and negative findings, have implications for evaluating the genetic architecture of patients with a family history of SCA, and for efforts to prevent SCA in high-risk populations and the general community.
KW - Genome-wide association study
KW - Mendelian randomization
KW - Sudden cardiac arrest
UR - http://www.scopus.com/inward/record.url?scp=85056802981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056802981&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehy474
DO - 10.1093/eurheartj/ehy474
M3 - Article
C2 - 30169657
AN - SCOPUS:85056802981
SN - 0195-668X
VL - 39
SP - 3961
EP - 3969
JO - European Heart Journal
JF - European Heart Journal
IS - 44
ER -